# Nicaragua Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Nicaragua HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Nicaragua (NIC)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $2.9M
- Products: 18
- Buyer markets: 14
- Average CAGR: +15.8%
- Global sector size: $295.5B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $191.6B | $247.5K | $70.1B | +2.6% | 10 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $6.8B | $77.8 | $9.6B | -10.4% | 2 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $11.3B | $55.2 | $7.6B | -32.3% | 1 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $17.6B | $119.0 | $7.6B | -12.1% | 4 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $9.7B | $33.9K | $6.9B | +196.6% | 4 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $13.3B | $627.7 | $5.1B | -23.8% | 4 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $8.5B | $2.6M | $4.3B | +12.4% | 1 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $6.6B | $994.1 | $4.1B | +3.6% | 2 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $9.3B | $6.0 | $3.6B | -34.1% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $5.5B | $144.9 | $3.1B | -15.2% | 4 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $2.4B | $49.2K | $2.4B | +59.4% | 2 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $2.3B | $6.1K | $2.1B | +11.1% | 2 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $100.4 | $2.0B | -10.5% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $1.8B | $23.4 | $1.2B | -15.0% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $590.4 | $803.3M | -10.5% | 1 | +0.0% |
| HS 300432 - Medicaments: containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | $1.9B | $0.5 | $746.4M | -32.3% | 1 | +0.0% |
| HS 340600 - Candles, tapers and the like | $1.0B | $4.9K | $640.8M | +28.3% | 1 | +0.0% |
| HS 330749 - Perfumes and deodorizors: perfuming or deodorizing preparations for rooms, (excluding those which operate by burning) | $676.1M | $4.3K | $579.1M | +35.9% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $53.6B calculated opportunity across 15 products.
- Switzerland, Liechtenstein (CHE): $27.7B calculated opportunity across 1 products.
- China (CHN): $9.0B calculated opportunity across 3 products.
- Canada (CAN): $8.3B calculated opportunity across 5 products.
- Germany (DEU): $7.5B calculated opportunity across 3 products.
- Netherlands (NLD): $7.0B calculated opportunity across 4 products.
- Mexico (MEX): $6.9B calculated opportunity across 3 products.
- France (FRA): $3.9B calculated opportunity across 2 products.
- Ireland (IRL): $3.2B calculated opportunity across 1 products.
- Spain (ESP): $2.0B calculated opportunity across 2 products.
- Republic of Korea (KOR): $1.1B calculated opportunity across 1 products.
- United Kingdom (GBR): $800.0M calculated opportunity across 1 products.

## Growth stars

- HS 382499: +196.6% average CAGR, $6.9B calculated opportunity.
- HS 382319: +59.4% average CAGR, $2.4B calculated opportunity.
- HS 330749: +35.9% average CAGR, $579.1M calculated opportunity.
- HS 340600: +28.3% average CAGR, $640.8M calculated opportunity.
- HS 300212: +12.4% average CAGR, $4.3B calculated opportunity.
- HS 340220: +11.1% average CAGR, $2.1B calculated opportunity.
- HS 330300: +3.6% average CAGR, $4.1B calculated opportunity.
- HS 300490: +2.6% average CAGR, $70.1B calculated opportunity.
- HS 330210: -10.4% average CAGR, $9.6B calculated opportunity.
- HS 330290: -10.5% average CAGR, $803.3M calculated opportunity.

## Diversification opportunities

- HS 300490: 10 buyer markets, $70.1B calculated opportunity.
- HS 330499: 4 buyer markets, $7.6B calculated opportunity.
- HS 382499: 4 buyer markets, $6.9B calculated opportunity.
- HS 382200: 4 buyer markets, $5.1B calculated opportunity.
- HS 300290: 4 buyer markets, $3.1B calculated opportunity.
- HS 330210: 2 buyer markets, $9.6B calculated opportunity.
- HS 330300: 2 buyer markets, $4.1B calculated opportunity.
- HS 382319: 2 buyer markets, $2.4B calculated opportunity.
- HS 340220: 2 buyer markets, $2.1B calculated opportunity.
- HS 300220: 1 buyer markets, $7.6B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.